How could lurbinectedin affect fertility?
Lurbinectedin (a chemotherapy medicine) can potentially affect fertility because many cancer treatments damage rapidly dividing cells and may injure the ovaries or reproductive hormone system. That kind of damage can make egg supply decline faster and can lead to temporary or, less commonly, permanent loss of ovarian function.
The specific risk with lurbinectedin depends on the dose, treatment schedule, and the patient’s age, baseline ovarian reserve, and whether other fertility-affecting treatments were used alongside it. [1]
Does it cause permanent infertility or just temporary changes?
Chemotherapy-associated fertility changes range from temporary delays in ovulation/menstruation to longer-lasting ovarian insufficiency. In practice, fertility outcomes after treatment are uncertain until months to years later, when menstrual cycles and hormone patterns can be reassessed.
For lurbinectedin specifically, the overall chance of permanent infertility is not something that can be precisely predicted from general chemotherapy knowledge alone; it requires fertility-preservation planning and individualized discussion. [1]
What do doctors usually monitor after treatment?
Clinicians typically assess fertility impact using symptoms (return of menstrual periods) and lab testing such as ovarian hormone levels and, when appropriate, ultrasound and fertility-reserve measures. Because recovery can take time, follow-up is often spaced out rather than assessed immediately after the last dose. [1]
What fertility-preservation options are there before starting lurbinectedin?
If preserving future fertility is a priority, options are usually considered before treatment begins, such as egg or embryo freezing (when feasible) and ovarian protection strategies in appropriate cases. The best approach depends on timing, cancer urgency, and whether the patient can safely undergo controlled ovarian stimulation. [2]
What should patients ask their oncology team?
Patients commonly ask:
- How likely is ovarian failure for their specific regimen and planned total dose?
- Whether lurbinectedin is being used alone or with other therapies that also affect fertility.
- How soon after treatment cycles should return and what timeline to expect.
- Whether a fertility specialist consult should happen before the first dose. [2]
When is the safest time to act?
Fertility-preservation steps generally need to happen before chemotherapy starts, because egg/ovary reserve can be affected by treatment. Waiting until after treatment starts can reduce the chance of successfully collecting eggs for freezing. [2]
Can someone still become pregnant after lurbinectedin?
Some people do become pregnant after chemotherapy, but pregnancy planning is individual and usually delayed until treatment is completed and the oncology team confirms it is medically appropriate. Doctors also weigh risks of pregnancy during treatment, potential effects on pregnancy outcomes, and the patient’s recovery of ovarian function. [1][2]
If you share the patient’s age and the treatment plan (whether lurbinectedin is alone or combined with other agents), I can tailor the questions and explain what typically drives higher vs lower fertility risk.
Sources:
[1] https://www.cancer.gov/publications/dictionaries/cancer-terms/def/infertility
[2] https://www.asrm.org/practice-guidance/fertility-preservation/